Denali Therapeutics Ownership | Who Owns Denali Therapeutics?
Denali Therapeutics Ownership Summary
Denali Therapeutics is owned by 69.52% institutional investors, 9.13% insiders, and 21.35% retail investors. Blackrock is the largest institutional shareholder, holding 8.82% of DNLI shares. Scottish Mortgage Ord is the top mutual fund, with 4.44% of its assets in Denali Therapeutics shares.
DNLI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Denali Therapeutics | 69.52% | 9.13% | 21.35% |
| Sector | Healthcare Stocks | 35.56% | 12.08% | 52.36% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 13.17M | 8.82% | $305.91M |
| Vanguard group | 13.06M | 7.57% | $215.59M |
| Blackrock funding, inc. /de | 14.03M | 7.52% | $360.76M |
| Baillie gifford | 11.96M | 6.41% | $307.62M |
| T. rowe price investment management | 8.52M | 4.86% | $163.57M |
| State street | 7.05M | 3.78% | $181.31M |
| Temasek (private) | 7.01M | 3.76% | $180.37M |
| Vanguard capital management | 6.28M | 3.36% | $161.41M |
| Goldman sachs group | 4.41M | 2.51% | $84.62M |
| Fmr | 4.54M | 2.43% | $116.66M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Crestline management, lp | 2.21M | 91.74% | $42.45M |
| Foresite capital management vi | 1.21M | 5.05% | $23.23M |
| Casdin capital | 1.84M | 2.68% | $35.33M |
| Stempoint capital lp | 426.56K | 1.59% | $8.19M |
| Cercano management | 625.00K | 1.55% | $16.07M |
| Dafna capital management | 318.50K | 1.39% | $6.12M |
| Boxer capital management | 250.00K | 1.16% | $3.63M |
| Privium fund management b.v. | 229.86K | 1.09% | $5.91M |
| Yiheng capital management | 469.98K | 1.01% | $6.82M |
| Vestal point capital, lp | 1.77M | 0.95% | $34.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 2.82M | 0.01% | 2.82M |
| Vestal point capital, lp | 1.77M | 0.95% | 1.31M |
| T. rowe price investment management | 8.52M | 0.11% | 1.27M |
| Alyeska investment group | 1.94M | 0.11% | 1.08M |
| Vanguard group | 13.06M | 0.00% | 1.06M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lynx1 capital management lp | 11.66K | 0.06% | -1.87M |
| Point72 asset management | - | - | -1.70M |
| Price t rowe associates inc /md/ | 2.46M | 0.01% | -1.45M |
| Flagship pioneering | - | - | -1.36M |
| Ubs asset management americas | 3.16M | 0.01% | -1.27M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 2.82M | 0.01% | 2.82M | $72.65M |
| Braidwell lp | 296.32K | 0.19% | 296.32K | $5.69M |
| Axa investment managers | 294.73K | 0.01% | 294.73K | $4.28M |
| Schonfeld strategic advisors | 226.20K | 0.02% | 226.20K | $3.28M |
| Balyasny asset management | 195.11K | 0.00% | 195.11K | $3.75M |
Sold Out
| Holder | Change |
|---|---|
| Truvestments capital | -1.00 |
| Curio wealth | -1.00 |
| Vermillion wealth management | -1.00 |
| Toronto dominion bank | -2.00 |
| Global financial private client | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 235 | -7.11% | 121,971,228 | -19.30% | 69 | 0.90% | 136 | - | 47 | -33.80% |
| Dec 31, 2025 | 69 | -71.60% | 34,419,053 | -74.60% | 19 | 0.32% | 37 | -70.63% | 15 | -76.92% |
| Sep 30, 2025 | 84 | -62.83% | 32,008,693 | -75.36% | 18 | 0.33% | 39 | -67.77% | 28 | -56.25% |
| Jun 30, 2025 | 230 | 4.07% | 137,233,427 | 3.48% | 80 | 1.33% | 122 | 14.02% | 66 | -17.50% |
| Mar 31, 2025 | 220 | -3.51% | 132,840,276 | 3.83% | 77 | 1.36% | 108 | -14.96% | 80 | 35.59% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Scottish Mortgage Ord | 7.04M | 4.44% | - |
| T. Rowe Price Capital Appreciation | 4.97M | 3.13% | 4.97M |
| Vanguard Health Care Inv | 4.40M | 3.03% | -5.17M |
| Vanguard Total Stock Mkt Idx Inv | 4.29M | 2.70% | 20.55K |
| Vanguard Morn Total Stk Mkt Idx Investor | 4.29M | 2.70% | 20.55K |
| iShares Russell 2000 ETF | 3.75M | 2.36% | -66.62K |
| Vanguard US Total Market Shares ETF | 3.33M | 2.29% | -161.11K |
| State Street® SPDR® S&P® Biotech ETF | 3.41M | 2.15% | 7.84K |
| Vanguard Small Cap Index | 3.09M | 1.95% | -15.08K |
| Baillie Gifford US Equity Growth | 3.04M | 1.91% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Schuth Alexander O. | COFO and Secretary | Sell | $71.62K |
| Jan 06, 2026 | Watts Ryan J. | President and CEO | Sell | $580.77K |
| Jan 06, 2026 | Schuth Alexander O. | COFO and Secretary | Sell | $284.10K |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | - | Buy | $20.95K |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | - | Buy | $1.91K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 1 |
| 2026 Q2 | - | - |
| 2026 Q1 | - | 2 |
| 2025 Q4 | 2 | - |
| 2025 Q3 | - | 4 |
DNLI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools